Company intelligence / Profile preview

Zhejiang Institute of Traditional Chinese Medicine

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

The company has developed at least one approved herbal medicine, Kunxinning Granules, for menopausal syndrome. There are two clinical trials associated with the company, but detailed results are not publicly available. The organization focuses on traditional Chinese medicine research and development.[4]

Therapeutic areas: Women's Health
Modalities: Herbal medicine
Industry: Biotech

Drug pipeline

3 assets

Huanghua Fuyantin Granules

Unknown

2 more assets in the full pipeline.

Request access →

Partnerships

Tasly Pharmaceutical Group Co., Ltd.

Beyond the preview

Go deeper on Zhejiang Institute of Traditional Chinese Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Institute of Traditional Chinese Medicine.

Explore the full profile